Skip to main content
Top
Published in: BMC Neurology 1/2012

Open Access 01-12-2012 | Research article

Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms

Authors: Elmar H Pinkhardt, Reinhart Jürgens, Dorothée Lulé, Johanna Heimrath, Albert C Ludolph, Wolfgang Becker, Jan Kassubek

Published in: BMC Neurology | Issue 1/2012

Login to get access

Abstract

Background

The basal ganglia (BG) are thought to play an important role in the control of eye movements. Accordingly, the broad variety of subtle oculomotor alterations that has been described in Parkinson's disease (PD) are generally attributed to the dysfunction of the BG dopaminergic system. However, the present study suggest that dopamine substitution is much less effective in improving oculomotor performance than it is in restoring skeletomotor abilities.

Methods

We investigated reactive, visually guided saccades (RS), smooth pursuit eye movements (SPEM), and rapidly left-right alternating voluntary gaze shifts (AVGS) by video-oculography in 34 PD patients receiving oral dopaminergic medication (PD-DA), 14 patients with deep brain stimulation of the nucleus subthalamicus (DBS-STN), and 23 control subjects (CTL);In addition, we performed a thorough review of recent literature according therapeuthic effects on oculomotor performance in PD by switching deep brain stimulation off and on in the PD-DBS patients, we achieved swift changes between their therapeutic states without the delays of dopamine withdrawal. In addition, participants underwent neuropsychological testing.

Results

Patients exhibited the well known deficits such as increased saccade latency, reduced SPEM gain, and reduced frequency and amplitude of AVGS. Across patients none of the investigated oculomotor parameters correlated with UPDRS III whereas there was a negative correlation between SPEM gain and susceptibility to interference (Stroop score). Of the observed deficiencies, DBS-STN slightly improved AVGS frequency but neither AVGS amplitude nor SPEM or RS performance.

Conclusions

We conclude that the impairment of SPEM in PD results from a cortical, conceivably non-dopaminergic dysfunction, whereas patients' difficulty to rapidly execute AVGS might be related to their BG dysfunction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pinkhardt EH, Kassubek J: Ocular motor abnormalities in Parkinsonian syndromes. Parkinsonism Relat Disord. 2011, 17: 223-230. 10.1016/j.parkreldis.2010.08.004.CrossRefPubMed Pinkhardt EH, Kassubek J: Ocular motor abnormalities in Parkinsonian syndromes. Parkinsonism Relat Disord. 2011, 17: 223-230. 10.1016/j.parkreldis.2010.08.004.CrossRefPubMed
2.
go back to reference Temel Y, Tan S, Vlamings R, Sesia T, Lim LW, Lardeux S, Visser-Vandewalle V, Baunez C: Cognitive and limbic effects of deep brain stimulation in preclinical studies. Front Biosci. 2009, 14: 1891-1901.CrossRef Temel Y, Tan S, Vlamings R, Sesia T, Lim LW, Lardeux S, Visser-Vandewalle V, Baunez C: Cognitive and limbic effects of deep brain stimulation in preclinical studies. Front Biosci. 2009, 14: 1891-1901.CrossRef
3.
go back to reference Hikosaka O, Takikawa Y, Kawagoe R: Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev. 2000, 80: 953-978.PubMed Hikosaka O, Takikawa Y, Kawagoe R: Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev. 2000, 80: 953-978.PubMed
4.
go back to reference Crevits L, Versijpt J, Hanse M, De Ridder K: Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson's patients. Neuropsychobiology. 2000, 42: 202-206. 10.1159/000026694.CrossRefPubMed Crevits L, Versijpt J, Hanse M, De Ridder K: Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson's patients. Neuropsychobiology. 2000, 42: 202-206. 10.1159/000026694.CrossRefPubMed
5.
go back to reference Hood AJ, Amador SC, Cain AE, Briand KA, Al-Refai AH, Schiess MC, Sereno AB: Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2007, 78: 565-570. 10.1136/jnnp.2006.099754.CrossRefPubMedPubMedCentral Hood AJ, Amador SC, Cain AE, Briand KA, Al-Refai AH, Schiess MC, Sereno AB: Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2007, 78: 565-570. 10.1136/jnnp.2006.099754.CrossRefPubMedPubMedCentral
6.
go back to reference Rascol O, Clanet M, Montastruc JL, Simonetta M, Soulier-Esteve MJ, Doyon B, Rascol A: Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems. Brain. 1989, 112 (Pt 5): 1193-1214.CrossRefPubMed Rascol O, Clanet M, Montastruc JL, Simonetta M, Soulier-Esteve MJ, Doyon B, Rascol A: Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems. Brain. 1989, 112 (Pt 5): 1193-1214.CrossRefPubMed
7.
go back to reference Sauleau P, Pollak P, Krack P, Courjon JH, Vighetto A, Benabid AL, Pelisson D, Tilikete C: Subthalamic stimulation improves orienting gaze movements in Parkinson's disease. Clin Neurophysiol. 2008, 119: 1857-1863. 10.1016/j.clinph.2008.04.013.CrossRefPubMed Sauleau P, Pollak P, Krack P, Courjon JH, Vighetto A, Benabid AL, Pelisson D, Tilikete C: Subthalamic stimulation improves orienting gaze movements in Parkinson's disease. Clin Neurophysiol. 2008, 119: 1857-1863. 10.1016/j.clinph.2008.04.013.CrossRefPubMed
8.
go back to reference Yugeta A, Terao Y, Fukuda H, Hikosaka O, Yokochi F, Okiyama R, Taniguchi M, Takahashi H, Hamada I, Hanajima R, Ugawa Y: Effects of STN stimulation on the initiation and inhibition of saccade in Parkinson disease. Neurology. 2010, 74: 743-748. 10.1212/WNL.0b013e3181d31e0b.CrossRefPubMed Yugeta A, Terao Y, Fukuda H, Hikosaka O, Yokochi F, Okiyama R, Taniguchi M, Takahashi H, Hamada I, Hanajima R, Ugawa Y: Effects of STN stimulation on the initiation and inhibition of saccade in Parkinson disease. Neurology. 2010, 74: 743-748. 10.1212/WNL.0b013e3181d31e0b.CrossRefPubMed
9.
go back to reference Rivaud-Pechoux S, Vermersch AI, Gaymard B, Ploner CJ, Bejjani BP, Damier P, Demeret S, Agid Y, Pierrot-Deseilligny C: Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry. 2000, 68: 381-384. 10.1136/jnnp.68.3.381.CrossRefPubMedPubMedCentral Rivaud-Pechoux S, Vermersch AI, Gaymard B, Ploner CJ, Bejjani BP, Damier P, Demeret S, Agid Y, Pierrot-Deseilligny C: Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry. 2000, 68: 381-384. 10.1136/jnnp.68.3.381.CrossRefPubMedPubMedCentral
10.
go back to reference Wark HA, Garell PC, Walker AL, Basso MA: A case report on fixation instability in Parkinson's disease with bilateral deep brain stimulation implants. J Neurol Neurosurg Psychiatry. 2008, 79: 443-447. 10.1136/jnnp.2007.117192.CrossRefPubMedPubMedCentral Wark HA, Garell PC, Walker AL, Basso MA: A case report on fixation instability in Parkinson's disease with bilateral deep brain stimulation implants. J Neurol Neurosurg Psychiatry. 2008, 79: 443-447. 10.1136/jnnp.2007.117192.CrossRefPubMedPubMedCentral
11.
go back to reference Benabid AL, Chabardes S, Mitrofanis J, Pollak P: Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol. 2009, 8: 67-81. 10.1016/S1474-4422(08)70291-6.CrossRefPubMed Benabid AL, Chabardes S, Mitrofanis J, Pollak P: Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol. 2009, 8: 67-81. 10.1016/S1474-4422(08)70291-6.CrossRefPubMed
12.
go back to reference Lang AE, Obeso JA: Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol. 2004, 3: 309-316. 10.1016/S1474-4422(04)00740-9.CrossRefPubMed Lang AE, Obeso JA: Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol. 2004, 3: 309-316. 10.1016/S1474-4422(04)00740-9.CrossRefPubMed
13.
go back to reference Antonini A, Isaias IU, Rodolfi G, Landi A, Natuzzi F, Siri C, Pezzoli G: A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J Neurol. 2011, 4: 579-585.CrossRef Antonini A, Isaias IU, Rodolfi G, Landi A, Natuzzi F, Siri C, Pezzoli G: A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J Neurol. 2011, 4: 579-585.CrossRef
14.
go back to reference Harrison J, Henderson L, Kennard C: Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment. J Neurol Neurosurg Psychiatry. 1995, 59: 499-506. 10.1136/jnnp.59.5.499.CrossRefPubMedPubMedCentral Harrison J, Henderson L, Kennard C: Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment. J Neurol Neurosurg Psychiatry. 1995, 59: 499-506. 10.1136/jnnp.59.5.499.CrossRefPubMedPubMedCentral
15.
go back to reference Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE: Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010, 25: 2649-2653. 10.1002/mds.23429.CrossRefPubMed Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE: Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010, 25: 2649-2653. 10.1002/mds.23429.CrossRefPubMed
16.
go back to reference Gibb WR, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988, 51: 745-752. 10.1136/jnnp.51.6.745.CrossRefPubMedPubMedCentral Gibb WR, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988, 51: 745-752. 10.1136/jnnp.51.6.745.CrossRefPubMedPubMedCentral
17.
go back to reference Lopiano L, Torre E, Benedetti F, Bergamasco B, Perozzo P, Pollo A, Rizzone M, Tavella A, Lanotte M: Temporal changes in movement time during the switch of the stimulators in Parkinson's disease patients treated by subthalamic nucleus stimulation. Eur Neurol. 2003, 50: 94-99. 10.1159/000072506.CrossRefPubMed Lopiano L, Torre E, Benedetti F, Bergamasco B, Perozzo P, Pollo A, Rizzone M, Tavella A, Lanotte M: Temporal changes in movement time during the switch of the stimulators in Parkinson's disease patients treated by subthalamic nucleus stimulation. Eur Neurol. 2003, 50: 94-99. 10.1159/000072506.CrossRefPubMed
18.
go back to reference Zgaljardic DJ, Borod JC, Foldi NS, Mattis PJ, Gordon MF, Feigin A, Eidelberg D: An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J Clin Exp Neuropsychol. 2006, 28: 1127-1144. 10.1080/13803390500246910.CrossRefPubMedPubMedCentral Zgaljardic DJ, Borod JC, Foldi NS, Mattis PJ, Gordon MF, Feigin A, Eidelberg D: An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J Clin Exp Neuropsychol. 2006, 28: 1127-1144. 10.1080/13803390500246910.CrossRefPubMedPubMedCentral
19.
go back to reference Temel Y, Visser-Vandewalle V, Carpenter RH: Saccadometry: a novel clinical tool for quantification of the motor effects of subthalamic nucleus stimulation in Parkinson's disease. Exp Neurol. 2009, 216: 481-489. 10.1016/j.expneurol.2009.01.007.CrossRefPubMed Temel Y, Visser-Vandewalle V, Carpenter RH: Saccadometry: a novel clinical tool for quantification of the motor effects of subthalamic nucleus stimulation in Parkinson's disease. Exp Neurol. 2009, 216: 481-489. 10.1016/j.expneurol.2009.01.007.CrossRefPubMed
20.
go back to reference Kuhn AA, Kempf F, Brucke C, Gaynor Doyle L, Martinez-Torres I, Pogosyan A, Trottenberg T, Kupsch A, Schneider GH, Hariz MI, et al: High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance. J Neurosci. 2008, 28: 6165-6173. 10.1523/JNEUROSCI.0282-08.2008.CrossRefPubMed Kuhn AA, Kempf F, Brucke C, Gaynor Doyle L, Martinez-Torres I, Pogosyan A, Trottenberg T, Kupsch A, Schneider GH, Hariz MI, et al: High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance. J Neurosci. 2008, 28: 6165-6173. 10.1523/JNEUROSCI.0282-08.2008.CrossRefPubMed
21.
go back to reference Pinkhardt EH, Kassubek J, Sussmuth S, Ludolph AC, Becker W, Jurgens R: Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease. J Neurol. 2009, 256: 1438-1446. 10.1007/s00415-009-5131-5.CrossRefPubMed Pinkhardt EH, Kassubek J, Sussmuth S, Ludolph AC, Becker W, Jurgens R: Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease. J Neurol. 2009, 256: 1438-1446. 10.1007/s00415-009-5131-5.CrossRefPubMed
22.
go back to reference Bares M, Brazdil M, Kanovsky P, Jurak P, Daniel P, Kukleta M, Rektor I: The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients. Parkinsonism Relat Disord. 2003, 9: 139-144. 10.1016/S1353-8020(02)00015-9.CrossRefPubMed Bares M, Brazdil M, Kanovsky P, Jurak P, Daniel P, Kukleta M, Rektor I: The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients. Parkinsonism Relat Disord. 2003, 9: 139-144. 10.1016/S1353-8020(02)00015-9.CrossRefPubMed
23.
go back to reference Nakamura T, Kanayama R, Sano R, Ohki M, Kimura Y, Aoyagi M, Koike Y: Quantitative analysis of ocular movements in Parkinson's disease. Acta Otolaryngol Suppl. 1991, 481: 559-562.CrossRefPubMed Nakamura T, Kanayama R, Sano R, Ohki M, Kimura Y, Aoyagi M, Koike Y: Quantitative analysis of ocular movements in Parkinson's disease. Acta Otolaryngol Suppl. 1991, 481: 559-562.CrossRefPubMed
24.
25.
go back to reference Weinberger M, Mahant N, Hutchison WD, Lozano AM, Moro E, Hodaie M, Lang AE, Dostrovsky JO: Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. J Neurophysiol. 2006, 96: 3248-3256. 10.1152/jn.00697.2006.CrossRefPubMed Weinberger M, Mahant N, Hutchison WD, Lozano AM, Moro E, Hodaie M, Lang AE, Dostrovsky JO: Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. J Neurophysiol. 2006, 96: 3248-3256. 10.1152/jn.00697.2006.CrossRefPubMed
26.
go back to reference Mosimann UP, Muri RM, Burn DJ, Felblinger J, O'Brien JT, McKeith IG: Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain. 2005, 128: 1267-1276. 10.1093/brain/awh484.CrossRefPubMed Mosimann UP, Muri RM, Burn DJ, Felblinger J, O'Brien JT, McKeith IG: Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain. 2005, 128: 1267-1276. 10.1093/brain/awh484.CrossRefPubMed
27.
go back to reference Chan PL, Nutt JG, Holford NH: Modeling the short- and long-duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson's disease. J Pharmacokinet Pharmacodyn. 2004, 31: 243-268.CrossRefPubMed Chan PL, Nutt JG, Holford NH: Modeling the short- and long-duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson's disease. J Pharmacokinet Pharmacodyn. 2004, 31: 243-268.CrossRefPubMed
28.
go back to reference Rieger JW, Kim A, Argyelan M, Farber M, Glazman S, Liebeskind M, Meyer T, Bodis-Wollner I: Cortical functional anatomy of voluntary saccades in Parkinson disease. Clin EEG Neurosci. 2008, 39: 169-174. 10.1177/155005940803900404.CrossRefPubMed Rieger JW, Kim A, Argyelan M, Farber M, Glazman S, Liebeskind M, Meyer T, Bodis-Wollner I: Cortical functional anatomy of voluntary saccades in Parkinson disease. Clin EEG Neurosci. 2008, 39: 169-174. 10.1177/155005940803900404.CrossRefPubMed
Metadata
Title
Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms
Authors
Elmar H Pinkhardt
Reinhart Jürgens
Dorothée Lulé
Johanna Heimrath
Albert C Ludolph
Wolfgang Becker
Jan Kassubek
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2012
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-12-5

Other articles of this Issue 1/2012

BMC Neurology 1/2012 Go to the issue